In the News

Activist Spotlight: Expect M&A or Director Battle at Del Frisco’s, The Deal Pipeline

December 12, 2018

In this Deal Pipeline article Keith Gottfried outlines a number of considerations companies need to evaluate before adopting a poison pill, otherwise known as a shareholder rights plan, in connection with activism campaigns. Among other observations, he notes that while the pill prevents the activist from accumulating more shares making it less likely that the insurgent wins a director-election contest as it can't accumulate as much shares and votes as it could without the pill, there are negatives.

Read the full Deal Pipeline story >>